Alt, J. and Bischoff, H. G. and Laack, H-E and Leistner, R. D. and Panse, J. and Reinmuth, N. and Schulz, C. and Grohe, C. (2018) A Phase 3, randomized study of first-line durvalumab (D) plus /- tremelimumab (T) plus platinum-based chemotherapy (CT) vs CT alone in extensive disease small-cell lung cancer (ED-SCLC): CASPIAN. ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl1). p. 103. ISSN 2296-5270, 2296-5262
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Petra Gürster |
| Date Deposited: | 23 Jun 2020 12:56 |
| Last Modified: | 23 Jun 2020 12:56 |
| URI: | https://pred.uni-regensburg.de/id/eprint/15425 |
Actions (login required)
 |
View Item |
